Acquired resistance against Listeria monocytogenes is a typical T helper (T h ) 1 dominated immune response, whereas T h 2 cytokines are thought to worsen listeriosis. We investigated effects of recombinant IL-13 (rIL-13) on the host response to L. monocytogenes in mice. Although IL-13 has been described as a T h 2 cytokine with deactivating anti-inflammatory activities, it was found to enhance antilisterial resistance. In vitro, rIL-13 increased IL-12 p40 and p70 production by bone marrow macrophages infected with L. monocytogenes. In vivo, numbers of viable bacteria in spleens and livers were decreased after treatment of mice with rIL-13. In addition, granuloma formation was impaired and NK cell activity of spleen cells was enhanced. At the onset of infection, frequencies of IL-12-producing cells were increased and numbers of IL-4-and IFN-γ-secreting cells were diminished in rIL-13-treated mice as compared to controls. In contrast, on day 6 after infection, IL-12, IL-4 and IFN-γ levels in rIL-13-treated animals were equal to or even higher than those in controls. Although direct activation of host macrophages by IL-13 is possible, we consider it more likely that IL-13 acted indirectly through stimulation of IL-12 production and inhibition of IL-4 release early after infection. In contrast, our data argue against an apparent role of IFN-γ in IL-13-induced antilisterial resistance.
Introduction
Murine IL-13 (originally designated P600) was detected by is generally assumed that activation of T h 2-type cells is screening cDNA libraries prepared from the mRNA of connegligible in listeriosis, neutralization experiments with anticanavalin A-activated T helper (T h ) cells. It was found to be IL-4 antibodies indicate exacerbating effects of endogenous produced by a number of T h 2 clones, few clones of the T h 1 IL-4 (9,10). A recent report has shown that murine mast cells phenotype but not by fibroblasts (1) . In vitro, it expresses rapidly produce IL-13 (11). One may, therefore, speculate similar activities on macrophages as IL-4. It enhances surface that IL-13 belongs to the early T h 2-promoting cytokines and expression of the mannosyl receptor and of MHC class I and thus interferes with antilisterial protection. In contrast, our II molecules, and decreases secretion of proinflammatory data demonstrate that IL-13 improves various aspects of cytokines in response to lipopolysaccharide stimulation. In resistance against listeriosis and hence suggest that it favors addition, it inhibits release of nitric oxide as well as cytotoxic protection rather than disease exacerbation. activity by bone marrow macrophages (BMM) against Leishmania major (2, 3) . As a corollary, IL-13 is considered as a member of the T h 2 cytokine family. In contrast to IL-4, however, Methods IL-13 fails to promote T cell growth (4) . We investigated the effects of recombinant IL-13 (rIL-13) on the immune response Mice and microorganisms of mice infected with L. monocytogenes, an intracellular bacterium which replicates inside professional and non-pro-C57BL/6 mice were raised in our own breeding colonies under specific pathogen-free conditions. L. monocytogenes fessional phagocytes (5) . Experimental listeriosis is a characteristic T h 1 cell controlled infection and effective protection EGD were routinely passaged in C57BL/6 mice. Bacteria were grown in Trypticase-soy broth (Life Technologies, Paisley, UK), largely depends on the activation of antibacterial mechanisms in infected macrophages by IFN-γ (5). Probably, induction of and aliquots were frozen and stored at -70°C until use. Numbers of viable organisms were determined by plating a potent T h 1 response in listeriosis is promoted by prompt IL-12 production by infected macrophages (6) (7) (8) Macrophage cultures rIL-13 or medium used to dissolve rIL-13 (designated as BMM were obtained in a serum-free culture medium as vehicle). At the time points post-infection (p.i.) indicated in described previously (14). BMM were harvested on day 9 Results, viable bacteria in spleens and livers were enumerated and seeded into flat-bottom microdilution plates (Nunc) at by plating serial 10-fold dilutions of organ homogenates on 1ϫ10 5 cells/well in Iscove's modified Dulbecco's medium Trypticase-soy agar. The c.f.u. were counted after 24 h of without additives. After stimulation with rIFN-γ for 24 h, macroincubation at 37°C. phages were infected with L. monocytogenes (1ϫ10 6 /well) in the presence or absence of rIL-13. Supernatants were Enzyme-linked immunospot (ELISPOT) assay harvested after 24 h of incubation and tested for IL-12 (p40) Groups of three mice were infected with 1ϫ10 4 L. monocytogby ELISA and for IL-12 (p70) by a bioassay. To test the enes and treated i.v. with 0.5 µg rIL-13 or vehicle. At the time antilisterial activity of BMM, cells were lysed with 0.1% saponin points indicated in Results, splenocytes were prepared and and viable bacteria were enumerated by plating 10-fold frequencies of IL-12 (p40), IL-4 and IFN-γ spot-forming cells dilutions on Trypticase-soy agar. (s.f.c.) were determined by the ELISPOT method (10,13). Briefly, Millititer filtration plates with 0.45 µm pore size (Millipore ELISA for IL-12 (p40) Eschborn, Germany) were coated with anti-IL-12 mAb (C17.8, IL-12 (p40) was measured in a two-site ELISA. The mAb 1 µg/ml), anti-IFN-γ mAb (R4-6A2, 2 µg/ml) or anti-IL-4 mAb C17.8 IgG2a was used for coating and biotinylated mAb [BVD4-1D11, 2 µg/ml (Dianova, Hamburg, Germany)]. Spleno-C15.6 IgG1 was employed for detection. Murine rIL-12 was cytes were seeded into the wells in Clicks/RPMI medium used as a standard. containing 10% FCS and 5ϫ10 -5 M 2-mercaptoethanol. After 16 h, biotinylated second-step antibodies (anti-IL-12 mAb Bioassay for IL-12 (p70) C15.6.7, 0.15 µg/ml), anti-IFN-γ mAb (AN-18.17.24, 0.25 µg/ ml) or anti-IL-4 mAb (GVD6-24G2, 0.15 µg/ml) were added.
The biologic activity of IL-12 (p70) was determined in culture For detection, streptavidin alkaline phosphatase and the supernatants from splenocytes and BMM by an antibody substrate 5-bromo-4-chloro-3-indolyl phosphate (Fluka, Basel, capture bioassay (15). Briefly, the anti-IL-12 (p40) antibody Switzerland) with nitroblue tetrazolium chloride (Fluka) as C17.8 was adsorbed to ELISA plates (20 µg/ml in 0.1 M catalyst were used. The s.f.c. were counted under a dissecting sodium carbonate buffer, pH 9.5) at 4°C overnight. Plates microscope at 32-fold magnification.
were washed and blocked with 5% FCS in PBS for 2 h at 37°C. After three washes, dilutions of rIL-12 standard or test Splenocyte supernatants supernatants were added (100 µl/well, 4°C, overnight). Plates were washed three times and splenocytes (5ϫ10 6 /ml) together Groups of three mice were infected with 1ϫ10 4 L. monocytogenes and treated i.v. with 0.5 µg rIL-13 or vehicle. At the time with 50 U/ml of rIL-2 were added to the plates. After 24 h of incubation, supernatants were collected and tested for IFN-γ points indicated in Results, splenocytes were prepared and seeded into round-bottom microdilution plates (Nunc, content by ELISA. The detection limit was 20 pg/ml.
rIL-13 interferes with granuloma formation
In intracellular bacterial infections, granulomatous lesions develop at sites of microbial growth (5) . To investigate the influence of rIL-13 on granuloma formation, liver sections were prepared and stained with hematoxylin & eosin (Fig. 2) . At days 1 and 3 p.i. granuloma formation was not detectable (data not shown). Mice infected with L. monocytogenes alone developed characteristic granulomatous lesions at day 6 p.i., whereas only small infiltrates of inflammatory cells were detected in livers of rIL-13-treated L. monocytogenes-infected mice. Administration of rIL-13 alone had no influence on liver morphology. Reduced lesion formation is consistent with known anti-inflammatory activities of IL-13 (4). Thus, rIL-13 curtailed formation of lesions which are considered as a harmful rather than a protective tissue response to L. monocytogenes.
Effect of rIL-13 on cytokine production by spleen cells of infected mice
The early cytokine milieu dominated by IL-12 and IFN-γ is considered essential for the development of a protective antilisterial T cell response (6) . In contrast, evidence suggests that early production of IL-4 worsens listeriosis (9,10). Because treatment of mice with rIL-13 enhanced resistance to L. monocytogenes and reduced granuloma formation in the liver, we analyzed the influence of rIL-13 on cytokine production by spleen cells from L. monocytogenes-infected C57BL/ 6 mice. Splenocytes were prepared at 1 h, 3 h, 24 h and day 6 p.i. The frequencies of IL-12 (p40), IL-4 and IFN-γ s.f.c. were determined ex vivo by ELISPOT. As shown in Fig. 3(A) , treatment of L. monocytogenes-infected mice with rIL-13 markedly increased frequencies of IL-12 (p40) s.f.c. at 1 and 3 h p.i., while numbers of IL-4 s.f.c. were reduced at 1 and 24 h p.i. (Fig. 3C) . Since the expression of IL-12 p40 and p35 at 24 h p.i. but slightly increased at day 6 p.i. (Fig. 3D) . At experiments did not exceed 10%. day 3 p.i., when maximum cytolytic activity of NK cells was measured (see below), the frequencies of IFN-γ s.f.c. were 1/161 in IL-13 treated mice and 1/80 in untreated mice. These Results data suggest that IL-13 impaired early IFN-γ production (probably by NK cells) and slightly increased subsequent rIL-13 enhances resistance of mice to L. monocytogenes IFN-γ secretion (probably by T h 1 cells). Treatment of naive To investigate the effects of rIL-13 on the course of mice with rIL-13 alone did not affect cytokine production (data L. monocytogenes infection, C57BL/6 mice were challenged not shown). According to these results, it is possible that ILi.v. with a sublethal inoculum of 1ϫ10 4 L. monocytogenes.
13 promoted protection against listeriosis indirectly through One group of mice received a single dose of rIL-13 i.v.
increased IL-12 and decreased IL-4 production. Our data, (0.5 µg/mouse) simultaneously with bacteria, and c.f.u. were however, do not support a major role of IFN-γ in IL-13-induced determined in spleens and livers at days 1, 3 and 6 p.i. As antilisterial resistance. shown in Fig. 1(A) , mice treated with rIL-13 at the time of challenge bore~1 log 10 lower bacterial burden in their spleens Effect of rIL-13 on IL-12 production by BMM over the whole observation period as compared to control infected mice treated with vehicle. Similar, though less As described above, rIL-13 increased the number of IL-12 (p40) s.f.c. in spleens of L. monocytogenes-infected mice as marked, c.f.u. reduction was found in livers of rIL-13-treated mice (Fig. 1B) . Thus, rIL-13 enhanced resistance against well as production of bioactive IL-12 (p70). To directly verify stimulatory effects of IL-13 on IL-12 production, in vitro studies listeriosis.
L. monocytogenes (18, 19) . Infection of rIFN-γ-activated BMM with L. monocytogenes in the presence of rIL-13 enhanced production of IL-12 (p40) (Fig. 4A) . As shown in Fig. 4(B) , rIL-13 also enhanced production of IL-12 (p70) by BMM, however, murine BMM secrete an excess of free IL-12 (p40). Pretreatment of BMM with rIL-13 before stimulation with rIFN-γ had no effect on IL-12 production (data not shown). These data demonstrate that IL-13 induced secretion of the T h 1-inducing cytokine IL-12 by macrophages when given simultaneously with listeriae. Stimulation of BMM with rIL-13 only marginally enhanced the antilisterial activity of macrophages as determined by c.f.u. (data not shown). Thus, direct effects of IL-13 on the antibacterial capacity of macrophages appear unlikely, at least in the in vitro setting.
Effects of rIL-13 on NK activity NK cells have been implicated in immune surveillance against tumors and intracellular pathogens, and NK cell activation by various bacteria including L. monocytogenes has been described (20) . Although the contribution of NK cells to antilisterial resistance is probably a function of IFN-γ secretion, NK cell activation is generally determined in vitro by lysis of sensitive target cells. We wondered whether rIL-13 influenced NK cell cytolytic activity. Mice were infected i.v. with L. monocytogenes and treated with rIL-13. At days 1, 3 and 6 p.i., nylon-wool non-adherent spleen cells were tested for NK activity. At day 1, NK activity was not detectable (data not shown). Maximum cytotoxicity against Yac-1 cells was measured at day 3 (Fig. 5) . Treatment with rIL-13 enhanced NK activity compared to non-infected and to L. monocytogenes challenged mice. At day 6 p.i., however, spleen cells had lost their NK potential (data not shown). As described above, IFN-γ secretion was still impaired at day 3 p.i. These results show that IL-13 is an inducer of NK cytolytic activity but does not enhance NK cell production of IFN-γ. A dissociation between NK cell cytolytic function and IFN-γ production has already been described in other systems (21,22).
Discussion
The purpose of our study was to investigate the potential role of IL-13 in the cytokine network which leads to cell-mediated immunity against intracellular pathogens. As a model system, the host response of mice to L. monocytogenes was chosen. At the onset of infection, macrophages phagocytose listeriae and rapidly release the monokines IL-12 and tumor necrosis factor (TNF)-α which stimulate NK cells to produce IFN-γ, the decisive cytokine in protective immunity against L. monocy- organ pathology, increased IL-12 and reduced IL-4 production in vitro and in vivo. Finally we found that IL-13 enhanced NK cell cytolytic activity and impaired early IFN-γ secretion.
Granulomatous lesions generally develop in response to using a virtually pure macrophage population were performed. BMM are potent IL-12 (p40) producers after stimulation with infections with intracellular bacteria at sites of microbial replication (5, (23) (24) (25) . Although granulomatous lesions are rIFN-γ and infection with Mycobacterium bovis BCG or responsible for tissue damage, they are considered of protectwere analyzed. Cytotoxicity against Yac-1 cells was measured at day 3 but was not demonstrable at days 1 and 6 p.i. ive value in chronic tuberculosis, because they contribute to pathogen containment within distinct lesions. In contrast, in Treatment of mice with rIL-13, either alone or in combination with L. monocytogenes increased NK cytotoxic activity on acute listeriosis, granulomatous lesions are dispensable for protection and their pathologic effects prevail (23) (24) (25) . Conday 3. In contrast, rIL-13 diminished early IFN-γ production up to day 6 p.i. We assume that both Yac-1 cell lysis as well sistent with this, rIL-13 administration decreased numbers of listeriae concomitant with diminished tissue pathology. We as IFN-γ production at day 3 of listeriosis were a function of NK cells. Hence, differential effects of rIL-13 on these two consider the reduction of lesion formation in listeriosis as a beneficial sequelae of IL-13 treatment. Similarly, rIL-12 was activities suggest segregation of IFN-γ secretion and NK cytolysis. Previous studies have already indicated a dissocifound to interfere with granuloma formation in mice infected with L. monocytogenes (26) or with Schistosoma mansoni ation between IFN-γ production and cytotoxic function of NK cells (21,22). Whilst IFN-γ production by NK cells is generally (27) . However, IL-12 also caused hepatotoxic effects in naive animals (28) . TNF-α and IFN-γ production induced by rIL-12 considered as an important part of early resistance against listeriosis, involvement of NK cytolytic activity in defense may form the basis of this toxicity. In contrast, rIL-13 did not induce apparent damage in non-infected mice probably against L. monocytogenes is less likely. Thus, our data do not support a contribution of NK cells to rIL-13-induced because IL-13 reduced IFN-γ synthesis at the onset of infection. It remains to be established whether rIL-13 directly antilisterial resistance. Analysis of cytokine production revealed that rIL-13 admininterfered with granuloma formation.
To find out how rIL-13 exerts its protective role, NK activity istered simultaneously with listeriae elevated IL-12 and decreased IL-4 production at early time points. It has been and cytokine production by spleen cells of infected mice increased protection (9,10). Direct stimulatory effects of rIL-13 on IL-12 production were demonstrated in vitro using a virtually pure macrophage population. BMM stimulated with rIFN-γ and infected with L. monocytogenes produced enhanced levels of IL-12 when rIL-13 was added simultaneously with listeriae. Together, these data emphasize that IL-13, generally considered as a T h 2-type cytokine, stimulates secretion of the T h 1-promoting cytokine IL-12 and curtails production of IL-4 which favors T h 2 differentiation.
Early production of IFN-γ was also decreased by IL-13 treatment. Thus, contribution of IFN-γ to rIL-13-induced resistance against listeriosis appears unlikely at the early phase of infection. At day 6 of listeriosis IFN-γ levels were slightly enhanced in rIL-13-treated mice. The role of this delayed IFN-γ increase in rIL-13-induced antilisterial resistance remains to be established. Since only a single dose of rIL-13 was administered at the onset of infection, it is likely that at day 6 p.i. IL-13 was exhausted resulting in delayed IFN-γ production.
The beneficial effects of rIL-13 on murine listeriosis could be explained by three alternatives, which are not mutually exclusive. First, since IL-4 and IL-13 share receptor compon- shown). Third, it is possible that rIL-13 increased resistance to listeriosis indirectly by enhancing IL-12 and decreasing IL-4 production. Although increased resistance against listeriosis in rIL-13-treated mice is probably multifactorial and shown that administration of rIL-12 improved resistance against listeriosis (26 shown that rIL-12 impairs IL-4 production in IFN-γ gene
